In Radiotherapy's first show back for 2023, Dr Sharma explores the decision by the Therapeutic Goods Administration (TGA) to permit psychiatrists in Australia to prescribe psilocybin for treatment resistant depression, and MDMA for post traumatic stress disorder (PTSD); Dr Dilemma explores the upcoming trial which will allow some pharmacists to prescribe basic medicines; Dr Neo unpacks the recent popularity of Semaglutide as a weight loss drug; and the team canvass the new Strengthening Medicare report. With presenters Panel Beater, Dr Dilemma, Dr Sharma, and Dr Neo.Website: https://www.rrr.org.au/explore/programs/radiotherapyFacebook: https://www.facebook.com/RadiotherapyOnTripleR/Twitter: https://twitter.com/_radiotherapy_Instagram: https://instagram.com/radiotherapy_tripler

Ver todos los episodios